Financials
- Market Capitalization 1.41 B
- Employee 435
- Founded 2005
- CEO N/A
- Website www.xerispharma.com
- Headquarter Illinois, United States
- FIGI BBG012V1MG52
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
—
Fiyat/satışlar oranı
4.65
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2185 | MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 20.41 USD | +0.25% | +9.14% | +8.28% | +113.49% | 1.50 B USD | ||
| 2204 | NVAX Novavax, Inc. - Common Stock | 8.91 USD | -4.50% | -4.60% | -2.84% | +26.92% | 1.47 B USD | ||
| 2263 | INBX Inhibrx Biosciences, Inc. - Common Stock | 92.17 USD | -0.90% | -4.49% | -3.10% | +14.38% | 1.35 B USD | ||
| 2306 | ARDX Ardelyx, Inc. - Common Stock | 5.14 USD | -2.65% | -4.10% | -10.45% | +11.02% | 1.27 B USD |